Gateways to clinical trials.

Area of Science:

• Pharmaceutical Sciences
• Drug Discovery and Development
• Medicinal Chemistry

Background:

• The pharmaceutical industry continuously explores novel therapeutic agents.
• A wide array of drug candidates, including small molecules, biologics, and vaccines, are under investigation.
• These agents target diverse disease areas, reflecting the breadth of medical research.

Purpose of the Study:

• To compile and present a list of pharmaceutical agents currently in development or under investigation.
• To provide an overview of the types of therapeutic modalities being explored.
• To serve as a reference for researchers and clinicians in the field of drug discovery.

Main Methods:

• Literature review and database compilation of pharmaceutical agents.
• Categorization of agents by therapeutic class and/or target indication.
• Inclusion of agents identified by unique codes or specific names.

Main Results:

• A comprehensive list of agents including Abacavir sulfate/lamivudine, Adalimumab, Artesunate/Amodiaquine, and numerous others is presented.
• The list encompasses small molecules (e.g., Aliskiren fumarate, Aprepitant), biologics (e.g., Bevacizumab, Denosumab), and vaccines (e.g., ETEC vaccine, Rotavirus vaccine).
• Agents are identified by their chemical names, brand names, or developmental codes.

Conclusions:

• The presented list underscores the extensive research and development efforts in creating new pharmaceutical treatments.
• The diversity of agents reflects a multi-pronged approach to addressing unmet medical needs.
• This compilation serves as a valuable resource for understanding the current pipeline of therapeutic interventions.